Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Alfa Aesar™ 1-Bromo-4-iodobenzene, 98%

Manufacturer:  Alfa Aesar™ A1385909

Quantity 10g

 View more versions of this product

Catalog No. AAA1385909


  Check Availability
Add to cart

Specifications

Description

Applications
It is mainly used as the OLED pharmaceutical intermediate, as reagent for in situ desilylation and coupling of silylated alkynes, as substrate in copper-free Sonogashira coupling in aqueous acetone. It is also used in synthesis of β,β,dibromostyrenes, as starting reagent in the total syntheses of ent-conduramine A and ent-7-deoxypancratistatin (alkaloids).

Solubility
Insoluble in water.

Notes
Light sensitive. Store in a cool, dry, well-ventilated area. Store away from oxidizing agent, light.
Description & Specifications

Chemical Identifiers

589-87-7
282.91
1904545
1-Bromo-4-iodobenzene
C6H4BrI
MFCD00001051
4-Bromoiodobenzene

Specifications

589-87-7
252°C
Recognizable
C6H4BrI
MFCD00001051
4-Bromoiodobenzene
98%
89° to 93°C
10g
98%
282.91
1904545
1-Bromo-4-iodobenzene

Safety and Handling

SDS & Safety Documents

GHS H Statement
H315-H319-H335
Causes skin irritation.
Causes serious eye irritation.
May cause respiratory irritation.

GHS P Statement
P280g-P305+P351+P338
Wear protective gloves.
IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing.

Warning

TSCA : TSCA

Provide Content Correction

We continue to work to improve your shopping experience and your feedback regarding this content is very important to us. Please use the form below to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Cancel Submit